| 1 |
CYP2D6 genotypes and phenotypes in Chinese Han, Uygur and Kazakh populations |
|
|
| Li, G.-C., Yang, J., Zhou, T., Chen, Z.-G., Chen, W. |
|
| Yaoxue Xuebao. 2011; 46(2): 238-242 |
|
| [Pubmed] [Google Scholar] |
|
| 2 |
Therapeutic effects of ciprofloxacin on the pharmacokinetics of carbamazepine in healthy adult male volunteers |
|
|
| Shahzadi, A., Javed, I., Aslam, B., Muhammad, F., Asi, M.R., Ashraf, M.Y., Zia-Ur-Rahman |
|
| Pakistan Journal of Pharmaceutical Sciences. 2011; 24(1): 63-68 |
|
| [Pubmed] [Google Scholar] |
|
| 3 |
An overview on the allelic variant of CYP2D6 genotype |
|
|
| Mathew, S. |
|
| African Journal of Biotechnology. 2010; 9(54): 9096-9102 |
|
| [Pubmed] [Google Scholar] |
|
| 4 |
Relationship of CYP2D6 genetic polymorphisms and the pharmacokinetics of tramadol in Chinese volunteers |
|
|
| Li, Q., Wang, R., Guo, Y., Wen, S., Xu, L., Wang, S. |
|
| Journal of Clinical Pharmacy and Therapeutics. 2010; 35(2): 239-247 |
|
| [Pubmed] [Google Scholar] |
|
| 5 |
Opioid analgesics and narcotic antagonists |
|
|
| Ghodse, A.H., Galea, S. |
|
| Side Effects of Drugs Annual. 2009; 31: 149-180 |
|
| [Pubmed] [Google Scholar] |
|
| 6 |
Rapid and reliable genotyping procedure for detection of alleles with mutations, deletion, or/and duplication of the CYP2D6 gene |
|
|
| Arneth, B., Shams, M., Hiemke, C., Härtter, S. |
|
| Clinical Biochemistry. 2009; 42(12): 1282-1290 |
|
| [Pubmed] [Google Scholar] |
|
| 7 |
Polymorphism of dextromethorphan oxidation in polish population |
|
|
| Skrȩtkowicz, J., Wojtczak, A., Rychlik-Sych, M. |
|
| Acta Poloniae Pharmaceutica - Drug Research. 2008; 65(5): 611-615 |
|
| [Pubmed] [Google Scholar] |
|
| 8 |
Role of pharmacogenomics in drug discovery and development |
|
|
| Surendiran, A., Pradhan, S., Adithan, C. |
|
| Indian Journal of Pharmacology. 2008; 40(4): 137-143 |
|
| [Pubmed] [Google Scholar] |
|
| 9 |
CYP2D6 phenotyping with dextromethorphan |
|
|
| Wojtczak, A., Rychlik-Sych, M., Krochmalska-Ulacha, E., Skretkowicz, J. |
|
| Pharmacological Reports. 2007; 59(6): 734-738 |
|
| [Pubmed] [Google Scholar] |
|
| 10 |
The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects |
|
|
| Lynch, T., Price, A. |
|
| American Family Physician. 2007; 76(3): 391-396 |
|
| [Pubmed] [Google Scholar] |
|
| 11 |
Pharmacogenetic screening of the gene deletion and duplications of CYP2D6 |
|
|
| Meijerman, I., Sanderson, L.M., Smits, P.H.M., Beijnen, J.H., Schellens, J.H.M. |
|
| Drug Metabolism Reviews. 2007; 39(1): 45-60 |
|
| [Pubmed] [Google Scholar] |
|
| 12 |
Simultaneous analysis of tramadol, metoprolol and their metabolites in human plasma and urine by high performance liquid chromatography |
|
|
| Li, Q., Wang, R. |
|
| Chinese Medical Journal. 2006; 119(23): 2013-2021 |
|
| [Pubmed] [Google Scholar] |
|
| 13 |
CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine |
|
|
| Shams, M.E.E., Arneth, B., Hiemke, C., Dragicevic, A., Müller, M.J., Kaiser, R., Lackner, K., Härtter, S. |
|
| Journal of Clinical Pharmacy and Therapeutics. 2006; 31(5): 493-502 |
|
| [Pubmed] [Google Scholar] |
|
| 14 |
Development of safer molecules through chirality |
|
|
| Patil, P.A., Kothekar, M.A. |
|
| Indian Journal of Medical Sciences. 2006; 60(10): 427-437 |
|
| [Pubmed] [Google Scholar] |
|
| 15 |
Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias |
|
|
| Aydin-Sayitogiu, M., Hatirnaz, O., Erensoy, N., Ozbek, U. |
|
| American Journal of Hematology. 2006; 81(3): 162-170 |
|
| [Pubmed] [Google Scholar] |
|
| 16 |
Frequency distribution of dextromethorphan O-demethylation in a Greek population |
|
|
| Kimiskidis, V.K., Niopas, I., Firinidis, P.D., Kanaze, F.I., Gabrieli, C., Kazis, D., Papagiannopoulos, S., Kazis, A. |
|
| International Journal of Clinical Pharmacology and Therapeutics. 2005; 43(3): 150-153 |
|
| [Pubmed] [Google Scholar] |
|
